ORKA insider trades & Congress trades
Oruka Therapeutics, Inc.: public insider filings and Congress disclosures, in one place.
Bourse has recorded 60 open-market insider transactions in Oruka Therapeutics, Inc. (ORKA) (0 purchases with code P and 60 sales with code S), the most recent on November 2, 2026.
In the last 90 days: 0 purchases by 0 insiders ($0) and 60 sales by 5 ($24.4M).
Insider transactions
SEC Form 4, open-market purchases (P) and sales (S) only. Awards, option exercises and tax withholding are excluded. “After” shows the stock’s return over the month following the trade, where available.
| Date | Insider | Role | Type | Shares | Price | Value | After 1M |
|---|---|---|---|---|---|---|---|
| Nov 2, 2026 | Klein Lawrence Otto | Chief Executive Officer | Sell | 6,466 | $94.77 | $613K | – |
| Nov 2, 2026 | Klein Lawrence Otto | Chief Executive Officer | Sell | 15,036 | $95.64 | $1.44M | – |
| Nov 2, 2026 | Klein Lawrence Otto | Chief Executive Officer | Sell | 2,442 | $96.70 | $236K | – |
| Nov 2, 2026 | Klein Lawrence Otto | Chief Executive Officer | Sell | 756 | $97.45 | $74K | – |
| Nov 2, 2026 | Klein Lawrence Otto | Chief Executive Officer | Sell | 300 | $98.40 | $30K | – |
| Oct 20, 2026 | Quinlan Paul T | General Counsel | Sell | 400 | $74.90 | $30K | – |
| Oct 20, 2026 | Quinlan Paul T | General Counsel | Sell | 500 | $76.12 | $38K | – |
| Oct 20, 2026 | Quinlan Paul T | General Counsel | Sell | 1,000 | $77.21 | $77K | – |
| Oct 20, 2026 | Quinlan Paul T | General Counsel | Sell | 4,100 | $78.79 | $323K | – |
| Oct 20, 2026 | Quinlan Paul T | General Counsel | Sell | 3,000 | $79.49 | $238K | – |
| Oct 15, 2026 | Goncalves Joana | Chief Medical Officer | Sell | 2,853 | $73.89 | $211K | – |
| Oct 15, 2026 | Goncalves Joana | Chief Medical Officer | Sell | 1,847 | $74.69 | $138K | – |
| Oct 15, 2026 | Goncalves Joana | Chief Medical Officer | Sell | 1,400 | $75.48 | $106K | – |
| Oct 15, 2026 | Goncalves Joana | Chief Medical Officer | Sell | 700 | $76.67 | $54K | – |
| Oct 15, 2026 | Goncalves Joana | Chief Medical Officer | Sell | 200 | $77.71 | $16K | – |
| Oct 12, 2026 | Agarwal Arjun | Senior Vice President, Finance | Sell | 5,741 | $80.03 | $459K | – |
| Oct 12, 2026 | Agarwal Arjun | Senior Vice President, Finance | Sell | 2,100 | $80.76 | $170K | – |
| Oct 12, 2026 | Agarwal Arjun | Senior Vice President, Finance | Sell | 1,958 | $81.86 | $160K | – |
| Oct 12, 2026 | Agarwal Arjun | Senior Vice President, Finance | Sell | 200 | $82.84 | $17K | – |
| Oct 1, 2026 | Klein Lawrence Otto | Chief Executive Officer | Sell | 16,246 | $83.40 | $1.35M | +0.1% |
| Oct 1, 2026 | Klein Lawrence Otto | Chief Executive Officer | Sell | 8,554 | $84.03 | $719K | +0.1% |
| Oct 1, 2026 | Klein Lawrence Otto | Chief Executive Officer | Sell | 200 | $84.78 | $17K | +0.1% |
| Sep 21, 2026 | Quinlan Paul T | General Counsel | Sell | 2,900 | $92.37 | $268K | – |
| Sep 21, 2026 | Quinlan Paul T | General Counsel | Sell | 3,832 | $93.32 | $358K | – |
| Sep 21, 2026 | Quinlan Paul T | General Counsel | Sell | 601 | $94.44 | $57K | – |
| Sep 21, 2026 | Quinlan Paul T | General Counsel | Sell | 2,667 | $95.31 | $254K | – |
| Sep 21, 2026 | Agarwal Arjun | Senior Vice President, Finance | Sell | 533 | $95.75 | $51K | – |
| Sep 15, 2026 | Sandler Laura Lee | Chief Operating Officer | Sell | 906 | $95.71 | $87K | −0.2% |
| Sep 15, 2026 | Quinlan Paul T | General Counsel | Sell | 1,039 | $95.71 | $99K | −0.2% |
| Sep 15, 2026 | Klein Lawrence Otto | Chief Executive Officer | Sell | 2,452 | $95.71 | $235K | −0.2% |
Showing the 30 most recent of 60 transactions.
Data as of November 8, 2026. Public filings only. A purchase or sale by a politician or an insider does not by itself imply any wrongdoing.
New to these filings? Read how to read a Form 4, how Congress trades are disclosed and what insider cluster buying means. Sources and limits are on the Methodology page.
See these filings as they land
Bourse collects Congress trades, SEC Form 4 insider filings and 13F fund holdings in one live feed, and flags insider buying clusters automatically. Free to start.
Bourse provides financial data and editorial information, parts of which are generated by AI. This page is for general education only. It is not personalised investment advice or a recommendation to buy or sell any financial instrument. Make your own decisions.